We chose to focus our studies on Mettl7a1, one of the candidate direct transcriptional targets of EPR (2), since our meta-analysis of publicly available proteomic datasets showed that human METTL7A is downregulated in breast cancer as well as in several other cancers (Supplementary Figure S1A). Here, TMT1A is linked to cancer.